Srinivas Chatla

524 total citations
19 papers, 409 citations indexed

About

Srinivas Chatla is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Srinivas Chatla has authored 19 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Srinivas Chatla's work include DNA Repair Mechanisms (4 papers), RNA Interference and Gene Delivery (3 papers) and Protein Degradation and Inhibitors (3 papers). Srinivas Chatla is often cited by papers focused on DNA Repair Mechanisms (4 papers), RNA Interference and Gene Delivery (3 papers) and Protein Degradation and Inhibitors (3 papers). Srinivas Chatla collaborates with scholars based in United States, India and China. Srinivas Chatla's co-authors include M. Janaki Ramaiah, S.N.C.V.L. Pushpavalli, Ähmed Kamal, Manika Pal‐Bhadra, Utpal Bhadra, G. Narahari Sastry, M. Naseer A. Khan, Rajesh V.C.R.N.C. Shetti, Aarti Juvekar and Mukesh Chourasia and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Srinivas Chatla

19 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Srinivas Chatla United States 10 217 184 69 69 27 19 409
Paul Erdman United States 10 185 0.9× 186 1.0× 63 0.9× 61 0.9× 24 0.9× 18 384
Jee Sun Yang South Korea 13 240 1.1× 153 0.8× 78 1.1× 35 0.5× 43 1.6× 17 419
Han-Li Huang Taiwan 12 277 1.3× 102 0.6× 98 1.4× 42 0.6× 30 1.1× 18 387
Deepak Bhattarai South Korea 13 272 1.3× 129 0.7× 95 1.4× 93 1.3× 40 1.5× 25 466
Yao Zhou China 11 299 1.4× 129 0.7× 67 1.0× 142 2.1× 28 1.0× 18 449
David K. Miyamoto United States 8 320 1.5× 110 0.6× 85 1.2× 42 0.6× 26 1.0× 9 406
Susan L. Hockerman United States 8 283 1.3× 211 1.1× 84 1.2× 81 1.2× 23 0.9× 9 461
Jennifer R. Thomason United States 11 195 0.9× 190 1.0× 115 1.7× 124 1.8× 34 1.3× 12 444
Shaun Fillery United Kingdom 11 334 1.5× 236 1.3× 121 1.8× 34 0.5× 23 0.9× 17 569
Feng‐Zhi Suo China 14 414 1.9× 132 0.7× 82 1.2× 38 0.6× 12 0.4× 19 554

Countries citing papers authored by Srinivas Chatla

Since Specialization
Citations

This map shows the geographic impact of Srinivas Chatla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivas Chatla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivas Chatla more than expected).

Fields of papers citing papers by Srinivas Chatla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srinivas Chatla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivas Chatla. The network helps show where Srinivas Chatla may publish in the future.

Co-authorship network of co-authors of Srinivas Chatla

This figure shows the co-authorship network connecting the top 25 collaborators of Srinivas Chatla. A scholar is included among the top collaborators of Srinivas Chatla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srinivas Chatla. Srinivas Chatla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Huan, Srinivas Chatla, Xiaolei Liu, et al.. (2025). ZNF251 haploinsufficiency confers PARP inhibitors resistance in BRCA1-mutated cancer cells through activation of homologous recombination. Cancer Letters. 613. 217505–217505. 3 indexed citations
3.
Golovine, Konstantin, Zhaorui Lian, Srinivas Chatla, et al.. (2023). ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias. Blood Cancer Journal. 13(1). 42–42. 3 indexed citations
4.
Wu, Limei, et al.. (2022). Hematopoietic stem cell regeneration through paracrine regulation of the Wnt5a/Prox1 signaling axis. Journal of Clinical Investigation. 132(12). 8 indexed citations
5.
Li, Xue, et al.. (2022). Persistent DNA damage and oncogenic stress-induced Trem1 promotes leukemia in mice. Haematologica. 107(11). 2576–2588. 5 indexed citations
6.
Wu, Limei, et al.. (2021). Quinacrine-CASIN combination overcomes chemoresistance in human acute lymphoid leukemia. Nature Communications. 12(1). 6936–6936. 9 indexed citations
7.
Chatla, Srinivas, et al.. (2021). Hematopoietic Stem Cell Regeneration through Paracrine Regulation of the Wnt5a-Prox1 Signaling Axis. Blood. 138(Supplement 1). 201–201. 1 indexed citations
8.
Chatla, Srinivas, et al.. (2019). Fancd2-deficient hematopoietic stem and progenitor cells depend on augmented mitochondrial translation for survival and proliferation. Stem Cell Research. 40. 101550–101550. 11 indexed citations
9.
Chatla, Srinivas, et al.. (2019). Inactivation of the NHEJ Activity of DNA-PKcs Prevents Fanconi Anemia Pre-Leukemic HSC Expansion. International Journal of Stem Cells. 12(3). 457–462. 3 indexed citations
10.
Kumar, M. Naveen, R. L. Babu, Rajeshwari H. Patil, et al.. (2018). Protein kinases orchestrate cell cycle regulators in differentiating BeWo choriocarcinoma cells. Molecular and Cellular Biochemistry. 452(1-2). 1–15. 5 indexed citations
11.
Kumar, Sushil, Ratnesh Kumar Srivastav, Srinivas Chatla, et al.. (2018). Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer. Oncogene. 38(12). 2092–2107. 73 indexed citations
13.
Chatla, Srinivas, et al.. (2016). Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma. APOPTOSIS. 21(11). 1249–1264. 23 indexed citations
14.
Chatla, Srinivas, M. Janaki Ramaiah, Lavanya Anumula, et al.. (2015). Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer. PLoS ONE. 10(11). e0142006–e0142006. 16 indexed citations
15.
Kamal, Ähmed, M. Janaki Ramaiah, Y. V. V. Srikanth, et al.. (2013). 3-Diarylethyne quinazolinones: a new class of senescence inducers. MedChemComm. 4(3). 575–575. 8 indexed citations
16.
Chandrasekhar, S., S.N.C.V.L. Pushpavalli, Srinivas Chatla, et al.. (2011). aza-Flavanones as potent cross-species microRNA inhibitors that arrest cell cycle. Bioorganic & Medicinal Chemistry Letters. 22(1). 645–648. 43 indexed citations
17.
Kamal, Ähmed, D. Dastagiri, M. Janaki Ramaiah, et al.. (2010). Synthesis of Imidazothiazole–Chalcone Derivatives as Anticancer and Apoptosis Inducing Agents. ChemMedChem. 5(11). 1937–1947. 57 indexed citations
18.
Kamal, Ähmed, K. Srinivasa Reddy, M. Naseer A. Khan, et al.. (2010). Synthesis, DNA-binding ability and anticancer activity of benzothiazole/benzoxazole–pyrrolo[2,1-c][1,4]benzodiazepine conjugates. Bioorganic & Medicinal Chemistry. 18(13). 4747–4761. 108 indexed citations
19.
Yadav, J. S., Basi V. Subba Reddy, Srinivas Chatla, & Srihari Pabbaraja. (2001). ChemInform Abstract: Ultrasound‐Promoted Deoxygenation of Sulfoxides by Samarium—NH4Cl.. ChemInform. 32(39). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026